Related Experiment Videos
The association between COPD and heart failure risk: a review
Javier de Miguel Díez1, Jorge Chancafe Morgan, Rodrigo Jiménez García
1Pulmonology Department, Gregorio Maranon University Hospital, Complutense University of Madrid, Madrid, Spain. jmiguel.hgugm@salud.madrid.org
Summary
Chronic obstructive pulmonary disease (COPD) and heart failure (HF) often coexist, worsening patient outcomes. Integrated management and further research are crucial for improving survival and quality of life in these patients.
Area of Science:
- Cardiology
- Pulmonology
- Internal Medicine
Background:
- Chronic obstructive pulmonary disease (COPD) and heart failure (HF) frequently coexist due to shared pathogenic mechanisms.
- Both conditions significantly increase morbidity and mortality, with a poorer prognosis when combined.
- Often, only one comorbidity is diagnosed, necessitating active screening for the other.
Purpose of the Study:
- To highlight the diagnostic challenges and therapeutic complexities of managing combined COPD and HF.
- To review current evidence on pharmacological and non-pharmacological treatments for comorbid COPD and HF.
- To advocate for an integrated management approach for these overlapping conditions.
Main Methods:
- Review of clinical practice observations and existing literature on COPD and HF comorbidities.
- Discussion of diagnostic tools such as plasma natriuretic peptides, lung function testing, and echocardiography.
- Analysis of therapeutic strategies, including beta-blockers, ACE inhibitors, ARBs, inhaled beta-agonists, and noninvasive ventilation.
Main Results:
- Selective beta-1 blockers are beneficial for stable HF patients with COPD.
- Statins, ACE inhibitors, and ARBs may reduce morbidity and mortality in COPD patients.
- Caution is advised with inhaled beta-2 agonists in HF patients with COPD; noninvasive ventilation improves outcomes in acute respiratory failure.
Conclusions:
- An integrated and combined approach is essential for managing patients with both COPD and HF.
- Further research into the pathogenesis and management of these comorbidities is needed.
- Improved management strategies aim to enhance both quality of life and survival for patients with COPD and HF.
Related Concept Videos
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...